Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL7684069 | 0.85 | GABRA1 (0.52) | GABRA1GABRB2MGLLTP53MAPT | |
| SCHEMBL132297 | 0.85 | HSPA5 (0.38) | CYP2D6 | |
| SCHEMBL36294 | 0.85 | GABRA1 (0.58) | GABRA1GABRB2MGLLTP53MAPT | |
| SCHEMBL25425763 | 0.85 | GABRA1 (0.58) | GABRA1GABRB2MGLLTP53MAPT | |
| SCHEMBL29390847 | 0.85 | GABRA1 (0.58) | GABRA1GABRB2MGLLTP53MAPT | |
| Benzene SCHEMBL3122858 | 0.82 | TP53 (0.56) | GABRA1GABRB2MGLLTP53MAPT | |
| SCHEMBL7542830 | 0.82 | GABRA1 (0.55) | GABRA1GABRB2MGLLTP53MAPT | |
| SCHEMBL14807864 | 0.82 | GABRA1 (0.55) | GABRA1GABRB2MGLLTP53MAPT | |
| Ammonia Solution, Strong SCHEMBL2638008 | 0.82 | GABRA1 (0.55) | GABRA1GABRB2MGLLTP53MAPT | |
| Benzene SCHEMBL11603070 | 0.82 | TP53 (0.56) | GABRA1GABRB2MGLLTP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112867706-A | MASP-2 inhibitors and methods of use | 奥默罗斯公司 | 2021-05-28 | — | — | CN | claimed |
| EP-3802489-A2 | MASP-2 INHIBITORS AND METHODS OF USE | Omeros Corporation (US) | 2021-04-14 | — | — | EP | claimed |
| US-9943501-B2 | PPAR-gamma activator | KOJUN JAPAN CO., LTD. (JP) | 2018-04-17 | — | — | US | claimed |
| EP-3167883-A1 | PPARy ACTIVATING AGENT | Kojun Japan Co. Ltd. (JP) | 2017-05-17 | — | — | EP | claimed |
| US-20170105965-A1 | PPAR-gamma ACTIVATOR | KOJUN JAPAN CO., LTD. (JP) | 2017-04-20 | — | — | US | claimed |
| CN-102584829-A | Pyrazole and pyrazine diketone derivative and application thereof | UNIV SHANDONG | 2012-07-18 | — | — | CN | claimed |
| CN-101367819-B | 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof | UNIV SHANDONG | 2010-08-18 | — | — | CN | claimed |
| CN-101633675-A | Preparation and application of 5-substituent group-6-substituent phenyl-2-ferrocenyl pyrazolo [1, 5-a] pyrazine-4(5H)-ketone derivative | UNIV SHANDONG | 2010-01-27 | — | — | CN | claimed |
| CN-101367819-A | 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof | UNIV SHANDONG (CN) | 2009-02-18 | — | — | CN | claimed |
| US-7304086-B2 | Inhibitors of glutaminyl cyclase | PROBIODRUG AG (DE) | 2007-12-04 | — | — | US | claimed |
| CN-1021281-C | ORGANIC PHOSPHORUS PESTICIDE COMPOSITIONS | STAUFFER CHEMICAL CO (US) | 1993-06-23 | — | — | CN | claimed |
| US-3930671-A | Color former and pressure-sensitive copying paper | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | claimed |
| CN-117964683-A | MASP-2 inhibitors and methods of use | 奥默罗斯公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117964684-A | MASP-2 inhibitors and methods of use | 奥默罗斯公司 | 2024-05-03 | — | — | CN | disclosed |
| US-11718758-B2 | Aqueous dispersion of colored particles | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-3725854-B1 | COLORED PARTICLE AQUEOUS DISPERSION | MITSUBISHI PENCIL CO (JP) | 2023-07-05 | — | — | EP | disclosed |
| EP-0051391-A1 | Bicyclic compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1982-05-12 | — | — | EP | disclosed |
| US-3996193-A | POLYALKYLENEPOLYAMINES, DIOLEFIN RUBBER | THE DOW CHEMICAL COMPANY (US) | 1976-12-07 | — | — | US | disclosed |
| US-3971825-A | (5,6) (10,11) BIS-METHYLENE, BRONCHODILATORS | SANKYO COMPANY LIMITED (JA) | 1976-07-27 | — | — | US | disclosed |
| US-3930671-A | Color former and pressure-sensitive copying paper | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170105965-A1 | PPAR-gamma ACTIVATOR | PPARG, PPARA, PPARD | GABRA1 244/4885GABRB2 165/4885MGLL 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.